In this study, two genes (AURKA and S1PR1) were screened as hub genes of OSU-2S treatment NSCLC by survival analysis and expression analysis, and the study has confirmed the tumour-growth-suppressive effect of OSU-2S in in vivo and in vitro experiments. The gene discussed is AURKA; the disease is neoplasm.